Tag: NASDAQ:LYEL

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lyell Immunopharma

Lyell Immunopharma Inc’s filing revealed that its Director BRAWLEY OTIS W acquired Company’s shares for reported $19958.0 on Mar 31

Lyell Immunopharma Inc’s recently made public that its Director Ramachandra Sumant acquired Company’s shares for reported $0.12 million on Mar

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its